Premarket Mover: Satsuma Pharmaceuticals Inc (STSA) Down 1.87%

Friday, April 28, 2023 08:18 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: Satsuma Pharmaceuticals Inc (STSA) Down 1.87%

Satsuma Pharmaceuticals Inc (STSA) is lower by Friday morning, with the stock falling -1.87% in pre-market trading to 1.05. STSA's short-term technical score of 17 indicates that the stock has traded less bullishly over the last month than 83% of stocks on the market. In the Biotechnology industry, which ranks 106 out of 146 industries, the stock ranks higher than 23% of stocks. Satsuma Pharmaceuticals Inc has risen 27.38% over the past month, closing at $0.70 on March 31. During this period of time, the stock fell as low as $0.66 and as high as $1.47. STSA has an average analyst recommendation of Buy. The company has an average price target of $2.00.

STSA has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on STSA!

See Full STSA Report

Satsuma Pharmaceuticals Inc has a Long-Term Technical rank of 54. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 46% of the market scoring higher. In the Biotechnology industry which is number 105 by this metric, STSA ranks better than 105% of stocks.

Important Dates for Investors in STSA:

-Satsuma Pharmaceuticals Inc is set to release earnings on 5/9/2023. Over the last 12 months, the company has reported EPS of $-2.20. -We do not have a set dividend date for Satsuma Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Satsuma Pharmaceuticals Inc (STSA)